Episodes 46-60 of 746
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Project Oncology®Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
GI InsightsDiagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
- advertisement
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Project Oncology®Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Deep Breaths: Updates from CHESTOptimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Deep Breaths: Updates from CHESTEvolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
Project Oncology®Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
- advertisement
Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Project Oncology®Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
